Metabolic Syndrome

Metabolic syndromeMetabolic syndrome sits across cardiology, endocrinology and hepatology, and the titles here treat it as the clustered cardiovascular risk state it is rather than as a diagnosis to be recorded. Central obesity, insulin resistance, atherogenic dyslipidaemia with raised triglycerides and low HDL, hypertension and hepatic steatosis are covered together, with the agents that now have cardiovascular and renal outcome data — GLP-1 receptor agonists and SGLT2 inhibitors — placed by the patient they suit. Practical management of rapid weight loss is addressed, including the micronutrient deficiencies that follow markedly reduced intake and the monitoring interval that catches them before symptoms. Dietary and activity material is written for the cuisines and constraints readers actually live with rather than an idealised pattern.
Metabolic syndromeMetabolic syndrome sits across cardiology, endocrinology and hepatology, and the titles here treat it as the clustered cardiovascular risk state it is rather than as a diagnosis to be recorded. Central obesity, insulin resistance, atherogenic dyslipidaemia with raised triglycerides and low HDL, hypertension and hepatic steatosis are covered together, with the agents that now have cardiovascular and renal outcome data — GLP-1 receptor agonists and SGLT2 inhibitors — placed by the patient they suit. Practical management of rapid weight loss is addressed, including the micronutrient deficiencies that follow markedly reduced intake and the monitoring interval that catches them before symptoms. Dietary and activity material is written for the cuisines and constraints readers actually live with rather than an idealised pattern.
Titles in this category are written for clinicians managing clustered cardiovascular risk in ordinary clinics rather than in specialist metabolic units, and they state the monitoring interval, the target and the point at which referral is appropriate. Patient-facing material in the category is proportionate about what dietary and activity change can achieve, and directs readers on glucose-lowering or cardiac medication to discuss substantial changes with their own doctor first.